Your email has been successfully added to our mailing list.

×
0 0 0 0 0 -0.00572961111788369 -0.0196879190540046 -0.0298975984395953
Stock impact report

FDA grants Breakthrough Therapy designation to Loxo Oncology's LOXO-292 [Seeking Alpha]

Loxo Oncology, Inc (LOXO)  More Company Research Source: Seeking Alpha
Last loxo oncology, inc earnings: 11/8 06:45 am Check Earnings Report
US:NASDAQ Investor Relations: ir.loxooncology.com
PDF FDA grants Breakthrough Therapy designation to Loxo Oncology's LOXO-292 [Read more]
Impact snapshot Event time: LOXO
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last price
VWAP
High:
Max up
High:
Low:
Max down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Opt-in for
LOXO alerts
from News Quantified
Opt-in for
LOXO alerts

from News Quantified
Opt-in for
LOXO alerts

from News Quantified